ABC Arbitrage’s Telix Pharmaceuticals TLX Stock Holding History

ABC Arbitrage’s Portfolio TLX Stock Details TLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-26,939	Closed	-$451K	–	277
2025 Q1	$451K	Buy	+26,939	New	+$471K	0.08%	158

Other funds holding TLX

Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

VPIM

Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ABC Arbitrage's TLX Position: Q2 2025 in Review

ABC Arbitrage sold out of Telix Pharmaceuticals (TLX) in Q2 2025, closing a stake of 26,939 shares — an estimated $451K sold.

ABC Arbitrage first reported a position in TLX in Q1 2025 and held it in 1 quarter. The position peaked at $451K in Q1 2025. 21 funds tracked by Wall St. Rank hold TLX as of Q2 2025.

ABC Arbitrage reported no remaining Telix Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
ABC Arbitrage sold 26,939 Telix Pharmaceuticals shares in Q2 2025, an estimated $451K.
ABC Arbitrage first reported a position in Telix Pharmaceuticals in Q1 2025 and held it in 1 quarter.
ABC Arbitrage's Telix Pharmaceuticals position peaked at $451K in Q1 2025.
21 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q2 2025.

Based on ABC Arbitrage's 13F filing for Q2 2025, filed 8 Aug 2025.